Suppr超能文献

缺血性脑卒中患者血清脂多糖中和能力。

Serum lipopolysaccharide neutralizing capacity in ischemic stroke.

机构信息

Oral and Maxillofacial Diseases, University of Helsinki, Helsinki, Finland.

Institute of Global Health, University of Heidelberg, Heidelberg, Germany.

出版信息

PLoS One. 2020 Feb 21;15(2):e0228806. doi: 10.1371/journal.pone.0228806. eCollection 2020.

Abstract

INTRODUCTION

Periodontitis is associated with increased serum lipopolysaccharide (LPS) activity, which may be one mechanism linking periodontitis with the risk of cardiovascular diseases. As LPS-carrying proteins including lipoproteins modify LPS-activity, we investigated the determinants of serum LPS-neutralizing capacity (LPS-NC) in ischemic stroke. The association of LPS-NC and Aggregatibacter actinomycetemcomitans, a major microbial biomarker in periodontitis, was also investigated.

MATERIALS AND METHODS

The assay to measure LPS-NC was set up by spiking serum samples with E. coli LPS. The LPS-NC, LPS-binding protein (LBP), soluble CD14 (sCD14), lipoprotein profiles, apo(lipoprotein) A-I, apoB, and phospholipid transfer protein (PLTP) activity, were determined in 98 ischemic stroke patients and 100 age- and sex-matched controls. Serum and saliva immune response to A. actinomycetemcomitans, its concentration in saliva, and serotype-distribution were examined.

RESULTS

LPS-NC values ranged between 51-83% in the whole population. Although several of the LPS-NC determinants differed significantly between cases and controls (PLTP, sCD14, apoA-I, HDL-cholesterol), the levels did not (p = 0.056). The main determinants of LPS-NC were i) triglycerides (β = -0.68, p<0.001), and ii) HDL cholesterol (0.260, <0.001), LDL cholesterol (-0.265, <0.001), PLTP (-0.196, 0.011), and IgG against A. actinomycetemcomitans (0.174, 0.011). Saliva A. actinomycetemcomitans concentration was higher [log mean (95% CI), 4.39 (2.35-8.19) vs. 10.7 (5.45-21) genomes/ml, p = 0.023) and serotype D more frequent (4 vs. 0%, p = 0.043) in cases than controls. Serotypeablity or serotypes did not, however, relate to the LPS-NC.

CONCLUSION

Serum LPS-NC comprised low PLTP-activity, triglyceride and LDL cholesterol concentrations, as well as high HDL cholesterol and IgG against A. actinomycetemcomitans. The present findings let us to conclude that LPS-NC did not associate with stroke.

摘要

简介

牙周炎与血清脂多糖(LPS)活性增加有关,这可能是牙周炎与心血管疾病风险相关的机制之一。由于携带 LPS 的蛋白质(包括脂蛋白)会改变 LPS 的活性,我们研究了缺血性中风患者血清 LPS 中和能力(LPS-NC)的决定因素。还研究了 LPS-NC 与牙周炎主要微生物生物标志物聚集放线杆菌之间的关联。

材料和方法

通过向血清样本中加入大肠杆菌 LPS 来建立测量 LPS-NC 的测定方法。在 98 名缺血性中风患者和 100 名年龄和性别匹配的对照者中,测定了 LPS-NC、LPS 结合蛋白(LBP)、可溶性 CD14(sCD14)、脂蛋白谱、载脂蛋白(脂蛋白)A-I、载脂蛋白 B 和磷脂转移蛋白(PLTP)活性。检测了血清和唾液对聚集放线杆菌的免疫反应、唾液中的浓度和血清型分布。

结果

整个人群的 LPS-NC 值范围在 51%-83%之间。尽管病例组和对照组之间的一些 LPS-NC 决定因素差异显著(PLTP、sCD14、apoA-I、HDL 胆固醇),但水平没有差异(p=0.056)。LPS-NC 的主要决定因素是 i)甘油三酯(β=-0.68,p<0.001),ii)HDL 胆固醇(0.260,<0.001),LDL 胆固醇(-0.265,<0.001),PLTP(-0.196,0.011)和针对聚集放线杆菌的 IgG(0.174,0.011)。与对照组相比,病例组唾液中聚集放线杆菌的浓度更高[对数平均值(95%CI),4.39(2.35-8.19)vs. 10.7(5.45-21)基因组/ml,p=0.023)和血清型 D 更为频繁(4 对 0%,p=0.043)。然而,血清型或血清型与 LPS-NC 无关。

结论

血清 LPS-NC 包含低 PLTP 活性、甘油三酯和 LDL 胆固醇浓度,以及高 HDL 胆固醇和针对聚集放线杆菌的 IgG。本研究结果表明,LPS-NC 与中风无关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/483c/7034831/2954534d1ddd/pone.0228806.g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验